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Abstract We have previously described a microarray
platform combining live basophils with protein arrays
suitable for high-throughput detection of sensitisation
against allergens. During optimisation of this technique,
we observed severe losses of adhering cells during the
washing steps, particularly after activation. In order to
preserve cell binding, we tested the cell adhesion char-
acteristics of different extracellular matrix proteins:
human collagen I, fibronectin (FN) from bovine plasma
and laminin (LN). FN was more effective than LN and
collagen. Cell detachment after activation was in part due
to reduced surface expression of VLA-4, the main ligand
for FN, which was significantly decreased within 15 min
of stimulation with 1 lg/mL calcium ionophore A23187,
reaching a minimum after 2 h then slowly recovering.
These optimised conditions were used for testing of well-
characterised sera from allergic patients using two newly
developed rat basophil leukaemia stable reporter cell lines
(RBL NF-AT/GFP and RBL NF-AT/DsRed), which both
express the human high-affinity IgE receptor alpha chain
(FceRIa). Both cell lines were able to detect sensitisation
to specific allergens showing the expected bell-shaped
dose–response curve, and correlated (R2 = 0.75) with the
standard beta-hexosaminidase assay, which is not suitable
for an array format.
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Introduction
Basophils and mast cells play a central role in allergic
reactions [1]. Crosslinking of Immunoglobulin E (IgE)
bound to cell surface high-affinity IgE receptor (FceRI)
with antigen triggers intracellular signalling events, leading
to multiple cellular responses involving cell degranulation
and release of various chemical mediators such as hista-
mine, chemokines, lipid mediators, and cytokines that
cause inflammation and common allergic symptoms [2].
Laboratory diagnosis of allergy is usually performed by
measuring levels of allergen-specific IgE (sIgE) in patients’
serum. Traditionally each suspected allergen is tested
individually, requiring larger amounts of serum and
increasing the overall cost. More recently, technological
advances have enabled the simultaneous assessment of
specific IgE levels for up to a hundred of allergens, either
using multiplex flow cytometry [3] or allergen arrays [4–6].
While these new technologies in combination with
recombinant or purified allergens allow component
resolved diagnosis of allergic sensitisation [7], there are
still unsolved issues regarding the clinical relevance of
specific IgE measurements, as the existence of specific IgE
binding does not always correlate with clinical symptoms.
False-positive results are obtained e.g. due to cross-reactiv-
ities with pan-allergens or IgE directed against cross-reactive
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carbohydrate determinants, which may not have the ability to
engage surface-bound IgE productively on mast cells and
basophils, and are thus often clinically irrelevant [8, 9].
A recent study found that the concordance between sIgE
measurements and skin prick tests (SPT) in allergy to
cow’s milk and hen’s egg is unexpectedly low [10]. Similar
inconsistencies between tests have also been reported for
allergy to hymenoptera venom [11]. As a result, diagnosis
of Type 1 Allergy is still best performed using a combi-
nation of sIgE, SPT, clinical history, and, in the case of
food allergy, oral challenge tests [12].
Thus there is clearly a need for more clinically relevant
diagnostic methods, while taking advantage of component
resolved diagnosis and the medium- to high-throughput
capacity of novel technologies. In a previous study, we
have demonstrated that humanised rat basophil leukaemia
(RBL) cell lines could be sensitised by human IgE or sera
from allergic patients and degranulation monitored in a cell
protein microarray system containing anti-IgE or matching
allergen [13]. During the optimisation of the procedure, we
observed that in the absence of fixation, sensitised baso-
phils detached from the array surface during washing after
activation. The degree of detachment strongly depended on
the type of stimulation used, whether proteins were used
for coating and the washing protocol.
Although receptor crosslinking is central to the degranu-
lation cascade, other processes potentiate the cell activation
process. The adhesion of mast cells and basophils to extra-
cellular matrix (ECM) proteins such as fibronectin (FN),
collagen (CO), laminin (LN) or vitronectin (VN) for instance
has been shown to play an important role in enhancing
degranulation of rat basophil leukaemia RBL-2H3 cells [14–
16]. RBL cells do not adhere to uncoated surfaces or show
any adherence in the absence of Ca2? [14]. RBL adherence to
ECM proteins is mediated by specific cell surface receptors
that belong to the integrin family [16].
Many integrins bind the tripeptide Arg-Gly-Asp (RGD)
sequence present on ECM proteins, originally described on
FN [17]. The b1 integrin subfamily in particular includes
receptors that bind to the ECM proteins FN, CO and LN,
and have been designed VLA (very late antigen) [18].
VLA-4 and VLA-5 have been shown to mediate RBL-2H3
cell adhesion to FN [16]. VLA-4 recognises the CS-1
sequence present in the type III connecting segment (IIICS)
of the cell-binding domain of FN, while VLA-5 recognises
the RGD sequences [16, 19].
Our long-term aim is to develop a fully automated
basophil array; in order to achieve this, two major obstacles
had to be overcome: the cell detachment during the
washing steps and the development of reporter systems
suitable for an array format. While a NF-AT–luciferase
reporter system has been recently developed by Nakamura
et al. [20] for diagnostic purposes, luciferase-based systems
require cell lysis before measurement of luciferase activity.
However, a lysis step will disconnect the signal from its
exact position on the array and is, therefore, not suitable in
this format. In this work, we describe optimised conditions
for the use of newly generated reporter systems which are
suitable for use in high-throughput formats such as allergen
arrays, providing a biological readout.
Materials and Methods
Cells and Cell Culture
All experiments were performed with rat basophilic leu-
kaemia cell line (RBL-703/21) transfected with the human
FceRI receptor a chain generated at Paul-Ehrlich-Institut
(Langen, Germany; kindly donated by Stefan Vieths and
Lothar Vogel). Cells were grown in MR 80/20 medium:
80 % (v/v) Minimal Essential Medium (MEM; GIBCO)
plus 20 % (v/v) RPMI-1640 medium (Sigma-Aldrich,UK)
supplemented with 5 % (v/v) heat-inactivated Foetal
bovine serum (FBS; GIBCO, UK), 2 mM L-glutamine,
50 IU/mL penicillin and 50 mg/mL streptomycin (Invit-
rogen, Paisley, UK). The transfected cells were cultured in
the presence of 1 mg/mL geneticin sulphate (G-418;
Sigma-Aldrich) at 37 C in a humidified atmosphere con-
taining 5 % CO2. Recombinant Allergens were from Greer
Labs (Canada).
Binding of Cells to Array Slides
Polyclonal goat anti-human IgE 0.5 mg/mL (Biosource,
Camarillo, CA, USA) was hand printed (*0.1 lL/spot)
onto 16-Pad FAST slides (Whatman Schleicher & Schuell,
Dassel, Germany). The diameter of each spot was
approximately 450 lm. The slides were then blocked with
3 % (w/v) BSA in PBS for 30 min at 37 C, dried, and
stored until use at room temperature. Before incubation
with the cells, slender strips of adhesive tape (Gene-Frame,
ABgene, Epsom, UK) were attached to margins of the
coated slide surface to produce a rectangular incubation
area for cell/protein interaction. The IgE- or serum-sensi-
tised rat basophilic cell lines were harvested and re-sus-
pended in 0.25 % (w/v) BSA in Dulbecco’s PBS (DPBS)
(Lonza, Belgium) at a density of 2.4 9 104 basophils/
100 lL and transferred onto the 16-Pad FAST slide. Cells
were incubated for 2 h at 37 C in a humidified atmosphere
with 5 % CO2. The slides were gently swirled manually for
10 s every 30 min. After incubation, unbound cells were
washed off the slide by loading onto a slide rack and
washing in a reservoir containing PBS at room temperature
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with gentle immersion and lifting for 5 s twice manually,
followed by fixation for at least 1 h in PBS containing
1 % (v/v) formaldehyde. Bound cells on FAST slides were
observed to be wet using a conventional light microscope
with a 49 objective lens. Images were captured and
quantified using Image Pro Plus software (Media Cyber-
netics, Bethesda, MD, USA) equipped with a Nikon
Micropublisher 3.3 RTV Labophot-2 camera (Qimaging,
Surrey, Canada) and were processed using Adobe Photo-
shop software.
Surface Expression of Human FceRI Receptor
In order to optimise culture conditions leading to the sur-
face expression of the human high-affinity IgE receptor,
RBL-703/21 cells were incubated with increasing concen-
trations of IgE for different lengths of time. Normal rat
serum was heat-treated (55 C, 30 min) to inactivate
complement and added to cells in medium at 10 % (v/v) in
order to reduce potential background staining caused by
non-specific antibody binding. Surface expression of
FceRIa was detected by mouse IgG2b CRA-1-FITC
monoclonal antibody (CosmoBio, Tokyo, Japan) which is
specific for the a-chain of human FceRI and does not
compete for IgE binding. FITC-labelled mouse IgG2b
monoclonal antibody specific for keyhole limpet haemo-
cyanin (KLH) was used as the isotype control (R&D Sys-
tems, UK). FITC-labelled antibodies (10 lg/mL) were
added to 1 9 105 RBL-703/21 in medium and incubated at
4 C for 30 min. These steps were performed under aseptic
conditions in the dark. Samples were then spun at 250 g for
5 min and washed in DPBS (without Ca2?/Mg2?) twice to
remove unbound antibody. Finally, cells were fixed in
0.5 % (v/v) formaldehyde in DPBS and analysed in a
FACScan flow cytometer (Beckman-Coulter, USA).
Adhesion Assay
FN from bovine plasma (Sigma-Aldrich, UK) was coated
at concentrations ranging from 0.625 to 20 lg/mL in a
Maxi-Sorp 96-well Elisa plate (Nunc, UK), with one 0.5 %
(w/v) bovine serum albumin (Millipore, UK) coated (neg-
ative control) and one uncoated well (blank control) at 4 C
overnight prior the assay. 1 9 106 cells/mL of RBL-703/21
were sensitised with human IgE (1 lg/mL) (AbD Serotec,
UK) o/n at 37 C/5 %CO2. After 16 h, untreated and IgE-
sensitised cells were re-suspended in serum-free medium to
a final concentration of 1 9 106 cells/mL. The pre-coated
ECM plate was blocked with 0.5 % (w/v) BSA (Millipore,
UK) at room temperature for 1 h. One group of the normal
cells and the human IgE-sensitised cells were induced with
calcium ionophore A23187 (1 lg/mL) (Sigma-Aldrich,
UK) and anti-human IgE (2 lg/mL) (Vector Labs, UK)
separately, cell suspension (100 lL) were immediately
added to each well of the plate, each condition in tripli-
cates, and incubated for 2 h at 37 C/5 %CO2. After
incubation, the unattached cells were removed by washing
by aspiration and replacing with fresh MR80/20 medium
three times. The bound cells were stained with 0.1 % (m/v)
crystal violet (Millipore, UK) for 10 min, lysed with 10 %
(v/v) acetic acid (Fisher, UK) and absorbance was read by a
microplate reader (Model 680 XR, Bio-Rad, USA) at
550 nm.
Immunofluorescence Flow Cytometry
The surface expression of VLA-4 integrin was analysed by
immunofluorescence flow cytometry. Untreated and IgE-
sensitised cells were harvested and resuspended as descri-
bed above. After washing, cells were incubated in the
absence or presence of calcium ionophore A23187
(1 lg/mL) (Sigma-Aldrich, UK) or polyclonal goat anti-
human IgE (2 lg/mL) (Vector Labs, UK) at 37 C/5 %CO2
for 0, 5, 30, 60, 120, 180 and 240 min, then incubated with
2.5 lg/mL fluorescein isothiocyanate (FITC)-conjugated
anti-human VLA-4 integrin antibody (Novus, UK) at 37 C
for 1 h. After two washes, cells were fixed with 0.5 % (v/v)
formaldehyde (Sigma-Aldrich, UK) on ice, and analysed in
a FACScan flow cytometer (Beckman-Coulter, USA). Data
were processed and analysed using Weasel software (WEHI,
Australia).
Construction of Reporter Cell Lines
The forward primer 50-ATAATTAAAGATCTGCAGAAC
TGTGAATGCGCAAACC-30 and reverse primer 50-ATA
ATTAATGAATTCGAGCTCGGTACCCGG-30 were used
to amplify the NF-AT enhancer from pNF-AT-hrGFP
plasmid (Stratagene, US), with overhangs and BglII and
EcoRI restriction sites, respectively (underlined). The for-
ward primer 50-ATATAATAGAATTCACCATGGATAG
CACTGAGAACGTCATCAAG-30 and reverse primer
50-ATATTTAATCTCGAGCTACTGGAACAGGTGGTGG
CGG-30 were used to amplify the DsRed-Express2 gene
from pDsRed-Express2-1 plasmid (Clontech, US) with
overhangs and EcoRI and XhoI restriction sites, respectively
(underlined). Cycling conditions used were: Initial denatur-
ation 94 C 600 s, followed by 35 cycles of denaturing
(94 C, 60 s), annealing (61 C, 60 s) and extension (72 C,
60 s) with a final extension (72 C, 600 s), on a GeneAMP
PCR system 9700 (Applied Biosystems, USA). PCRs were
performed using AmpliTaq Gold DNA Polymerase (Invit-
rogen, UK). To construct the NF-AT/DsRed plasmid, the
NF-AT enhancer and DsRed-Express2 PCR products were
sequentially ligated into pUB6/V5-His A (Invitrogen, UK)
plasmid using T4 DNA ligase (Promega, UK) after digestion
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of vector with appropriate restriction enzymes as indicated
above. DNA sequences were verified by DNA sequencing
(Sigma-Aldrich, UK). pNF-AT-hrGFP and NF-AT/DsRed
plasmids were amplified in DH5a E. coli and purified using a
Plasmid Maxi Kit (QIAGEN, Germany) using standard
molecular biology protocols and following the manufac-
turer’s supplied instructions, respectively. Plasmid purity was
assessed by OD260/280 on a Nanodrop 1000. Each plasmid
was transfected into RBL-703/21 cells by electroporation. In
a 4-mm electroporation cuvette (Bio-Rad, US), 15 lg plas-
mid was added to 4 9 106 cells in 100 lL MR80/20 med-
ium. Electroporation was carried out at 250 V, 250 lF in a
GenePulser Xcell (Bio-Rad, UK). Cells were transferred
from the cuvette into 6-well plates containing cell culture
medium. 3 days after transfection, stable transfectants were
selected using 1 mg/mL hygromycin B (Invitrogen, UK) for
pNF-AT-hrGFP transfectants and 20 lg/mL blasticidin S
(Invitrogen, UK) for NF-AT/DsRed transfectants. After
6-week selection by hygromycin B, or 1-week selection using
blasticidin S, cells were activated using 1 lg/mL human IgE
(AbD Serotec, UK) and 2 lg/mL anti-human IgE (Vector
Laboratories, UK), and single fluorescent cells were sorted
into each well of 96-well plates using a MoFlo cell sorter
(Beckman Coulter, USA). The most responsive clones, as
indicated by the highest fluorescence after activation,
were chosen and maintained in 1 mg/mL hygromycin B or
20 lg/mL blasticidin S.
Reporter Assay
Reporter gene activation was measured in 384-well plates
due to the unavailability of suitable instrumentation with
the ability to image array-bound fluorescent cells in a wet
environment at sufficiently high resolution (see ‘‘Discus-
sion’’). The wells were pre-coated with 20 lg/mL FN at
4 C overnight. Cells were then seeded at a density of
50,000 cells/well and sensitised overnight with 1:20 or
1:40 diluted serum of allergic patients or monoclonal
myeloma IgE (1 lg/mL) in 30 lL of MR 80/20 medium.
The next day, the medium was replaced with fresh cell
culture medium to remove unbound IgE before adding
recombinant Bet v1, Phl p1 (both from Biomay AG,
Vienna, Austria), Par j2 allergen (Bial Industrial Farm-
ace´utica S.A, Bilbao, Spain) or 2 lg/mL polyclonal anti-
human IgE antibody (Vectorlabs, Peterborough, UK) as
positive control for induction. Activation of reporter cell
lines was measured after 20 h using a Typhoon Trio
Scanner (Amersham Bioscience, Sweden) at Ex:Em:
488/520 nm for NF-AT-hrGFP-transfected cells, and
Ex/Em: 532/580 nm, for NF-AT-DsRed-transfected cells.
Fluorescence intensity in each well was quantified and
analysed by Image Quant software (Gel Life Science,
USA). Fluorescent images were taken with an EVOS fl
microscope (Advanced Microscopy Group, Mill Creek,
Washington) at the indicated magnification.
Statistical Analysis
Statistical analysis was performed using a two-tailed Stu-
dent’s t test. p values \0.05 were considered statistically
significant (*p \ 0.05; **p \ 0.01, or ***p \ 0.001).
Multiple comparisons were performed with ANOVA and
post-hoc Tukey or Bonferroni tests using IBM SPSS Sta-
tistics Version 16 (IBM, NY, USA).
Results
Effect of IgE Sensitisation on FceRIa Chain Expression
and Array Binding
A time course experiment was set up to determine the
optimal incubation time for the sensitisation of the hu-
manised cell line. In this experiment the RBL-703/21 cell
line was incubated with 10 lg/mL monoclonal human IgE
for various lengths of time. After incubation, sensitised cell
lines were harvested and bound to array slides as described
in Methods. Polyclonal anti-human IgE was used for cap-
ture in these experiments. Flow cytometric analysis of
FceRI receptor demonstrated (Fig. 1, bars) that longer IgE
sensitisation times resulted in higher surface expression of
FceRIa chains, reaching a plateau after 8–10 h. Longer IgE
incubation time also resulted in a larger number of cells
Fig. 1 Time course of RBL-703/21 binding to IgE-coated microarray
per unit area. RBL-703/21 cells were sensitised with 10 lg/mL
monoclonal human IgE-FITC for different lengths of time and
captured on FAST slides coated with polyclonal anti-human IgE.
After washing and fixation, images were taken and the number of
cells captured was determined by image analysis (left axis, full
circles). Surface-bound IgE was measured by flow cytometry and
expressed as Median Fluorescence intensity (right axis, bars). Data
are expressed as mean ± SD of three separate experiments
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immobilised to the membrane array displaying similar
kinetics. Sensitisation time in excess of 10 h did not
increase surface expression of FceRI a chains and did not
increase the density of cells bound to the anti-IgE spots on
the array (dark circles in Fig. 1).
Cell Density Experiment
Cell density experiments were carried out to determine the
optimal cell number for cell binding to FAST slides. In
these experiments, RBL-703/21 cells were sensitised with
2 % patient serum or 10 lg/mL monoclonal human IgE for
16 h at 37 C in humidified air containing 5 % CO2.
Sensitised cell lines were then harvested and different
amounts of cells were incubated with the array pads fol-
lowing the standard binding protocol. Again polyclonal
anti-human IgE was used for capture in these experiments.
As shown in Fig. 2, increasing cell densities applied to the
array resulted in higher densities of bound cells, as
expected. Sensitisation with 2 % patient serum was less
efficient than myeloma IgE, but still resulted in dose-
dependent cell adhesion to the array. The stronger attach-
ment using myeloma IgE was probably due to the higher
IgE concentration used compared with serum, allowing
complete occupancy and/or upregulation of high-affinity
IgE receptor on the cells, thus stronger interaction with the
polyclonal antibody used for cell binding to the FAST
slide.
Inclusion of FN Increases Adhesion
IgE-sensitised RBL-703/21 cells bound to FN in a dose-
dependent manner (Fig. 3a), with the highest binding at a
concentration of 20 lg/mL. Activation with anti-human
IgE antibody enhanced cell adhesion compared with IgE
alone (control, Fig. 3b, c) at suboptimal FN concentrations
(0.625–10 lg/mL, Fig. 3a). Addition of calcium ionophore
A23187 caused marked cell detachment from FN within
the 2-h incubation period (Fig. 3d), even with the highest
used FN concentration. Detachment of cells after activation
in the absence of FN was also seen in anti-IgE-stimulated
cells (Fig. 3e), albeit less pronounced than with the cal-
cium ionophore.
VLA-4 is Strongly Downregulated by A23187
but not by IgE-Dependent Activation
Because of the strong detachment observed after A23187
stimulation even in the presence of 20 lg/mL FN as
coating agent, we assessed the surface expression of
VLA-4, the main FN receptor on RBL cells [16]. As shown
in Fig. 4, flow cytometric analysis of surface VLA-4
expression clearly demonstrated a fast downregulation of
the integrin already measurable 15 min after addition of
A23187, reaching a maximum after 2-h incubation, then
recovering steadily in the next 2 h. In contrast, IgE-
dependent activation did not result in measurable changes
in surface VLA-4 levels, and was very similar to sensitised,
unstimulated cells.
The strong, progressive downregulation of VLA-4 after
A23187, but not anti-IgE stimulation, may explain the
stronger and almost complete detachment of cells seen with
ionophore stimulation. To the best of our knowledge, this is
the first report of a differential VLA-4 integrin downreg-
ulation on RBL cells upon receptor-mediated versus non-
receptor-mediated stimulation.
Differential Effects of FN, CO and LA on Cell
Attachment After Activation
Next we assessed the effect of different ECM proteins on
RBL-703/21 attachment during activation. All three ECM
were used at 20 lg/mL, which had shown the highest cell-
binding capability for FN. As shown in Fig. 5, receptor-
independent stimulation with A23187 led to more than
60 % cell detachment during washes in the presence of FN
or type I CO but only approximately 25 % with LA. FceRI-
dependent stimulation appeared to lead to increased bind-
ing for FN, although this did not achieve statistical sig-
nificance, but not for CO and LA. In the latter case,
ionophore or FceRI-dependent resulted in a similar loss of
cells after activation despite the presence of LA; however,
Fig. 2 Binding of cells per unit area in dependence of initial cell
density added to the array slides. RBL-703/21 cells were sensitised
overnight with 2 % human serum (crosses, dotted line) or myeloma
IgE (black circles, continuous line) and captured with polyclonal IgE
printed on FAST slides. Varying cell densities were incubated with
the arrays and the total amount of cells bound evaluated as described
in Methods. Data are shown as mean ± SD of three separate
experiments. Sigmoidal best fit curves for both conditions are shown
140 Mol Biotechnol (2014) 56:136–146
123
cell detachment was less pronounced than with FN or CO.
Furthermore, we also compared human with bovine FN but
saw no difference between the two (data not shown).
NF-AT-GFP and NF-AT-DsRed are Induced After
Allergen-Dependent IgE Crosslinking
Based on the results shown above, all subsequent experi-
ments were performed in the presence of 20 lg/mL FN.
Our next aim was to use these optimised conditions with
suitable RBL reporter cell lines, as the array format
requires that the activation marker used for assessment of
activation remains confined to the cells, in contrast to
soluble mediators such as histamine or beta-hexosamini-
dase, which are released by activated RBL cells.
For this purpose, we transfected a commercial NF-AT-
hrGFP reporter into the humanised RBL-703/21 cell line.
Stable transfectants were selected and underwent several
rounds of flow cytometry sorting as described in the
Methods section. The obtained stable transfectant cell line
(RBL NF-AT/GFP) was sensitised with serum of a patient
allergic to grass pollen and stimulated with several dilu-
tions (ranging from 1:102 to 1:109) of a 1 mg/mL solution
of Bet v1 and Phl p1 allergens (Fig. 6a). These experiments
were performed in 384-well plates instead of microarrays
due to the unavailability of equipment able to measure cell
arrays without drying and fixation (see discussion). Cells
were bound to the bottom wells coated with 20 lg/mL FN
and sensitised for 16 h with Bet v1 and Phl p1 allergic
patient serum diluted 1:40 (v/v). After addition of allergen,
Fig. 3 a Attachment of RBL-
703/21 cells to FN. Different
concentrations of FN
(0.625–20 lg/mL) were used
for coating, cells were activated
with 1 lg/mL A23187,
2 lg/mL anti-IgE, or left
untreated (control). 120 min
after activation, cells were
washed three times and the
amount of adherent cells was
quantified by a colorimetric
assay using crystal violet. Data
expressed are mean ± SD from
triplicate determinations.
Representative of three
independent experiments with
comparable results. Multiple
comparison for two variables
was obtained with a two-way
ANOVA with Bonferroni post-
hoc test to assess the statistical
significance of FN and the type
of stimulation for cell
attachment/detachment. There
was a highly significant effect of
FN (F(5,32) = 163.458,
p \ 0.001) and the type of
stimulation
(F(2,36) = 611.867, p \ 0.001)
on cell attachment. b–e 950
Light microscopy magnification
of RBL 703-21 cells, after 2-h
binding to 20 lg/mL FN
without stimulation (b),
activation with 2 lg/mL anti-
IgE with FN (c), or activation
with 1 lg/mL A23187 with FN
(d), or activated with 2 lg/mL
anti-IgE without FN coating (e)
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cells were incubated for a further 20 h, and fluorescence
was measured.
As shown in Fig. 6a, fluorescence levels showed a
dose-dependent bell-shaped curve with a broad optimum.
Figure 6b illustrates the related set of control conditions,
with unstimulated cells (cell only), cells sensitised with
IgE but unstimulated (IgE only), unsensitised and anti-
IgE-stimulated cells (anti-IgE only), IgE-sensitised and
anti-IgE-stimulated cells (IgE?anti-IgE), serum-sensitised,
unstimulated cells (serum only), and serum-sensitised
anti-IgE-stimulated cells (serum?anti-IgE). These results
show that an increase in GFP fluorescence (Fig. 6c) is only
obtained when IgE-sensitised cells are activated by cross-
linking agents (either allergen in Fig. 6a or anti-IgE anti-
bodies in Fig. 6b). There was a small, but statistically
significant fluorescence increase in serum treated but
unstimulated cells, which may be attributed to low-level
NF-AT translocation caused by monomeric IgE binding to
the high-affinity receptor [21]. However, the fact that we
did not find any effect of incubation with monoclonal
myeloma IgE seems to exclude this explanation. As we did
not find a similar increase with the DsRed reporter system
(Fig. 8b), it is more likely to be caused by intrinsic dif-
ferences between clones, rather than reflecting activation
by monomeric IgE.
However, the data in Fig. 6b also show that there is a
low signal-to-noise ratio of approximately twofold under
the best activation conditions, due at least in part to the
high background autofluorescence of the cells at the
wavelength used for GFP measurement [22]. This raised
the question whether the use of the reporter cell lines had
sufficient discriminatory power in comparison with the
traditional assay based on measurement of beta-hexosa-
minidase which is released by activated cells during
degranulation. Therefore, we determined the correlation
between the activation of the GFP reporter cell line and the
traditional beta-hexosaminidase biochemical assay by
testing in parallel using the same sera/allergen and IgE/
anti-IgE-positive controls. As shown in Fig. 7, overall
there was a reasonable degree of correlation (R2 = 0.7564)
with no visible trend for improved correlation in any range
of activation.
In order to improve the unacceptably low signal-to-noise
ratio and fluorescence intensity of GFP proteins in this
system, a new reporter system was constructed by linking
the NF-AT promoter sequence with a DsRed reporter gene.
Positive and stable transfectants were selected using blas-
ticidin followed by several rounds of FACS selection as
described in the Methods section. As demonstrated in
Fig. 8, the use of DsRed as reporter fluorescent protein
instead of GFP improved the signal-to-noise ratio, which
was approximately fivefold for the positive controls
Fig. 4 Time course of VLA-4 Integrin surface expression on RBL-
703/21 cells stimulated with anti-IgE or 1 lg/mL A23187. Data are
expressed as mean ± SD from three independent experiments. MFI
values were normalised to 100 % for the unstimulated, unsensitised
cells within each experiment. One-way ANOVA was used to
determine statistical significance in changes of surface levels of
VLA-4 after stimulation. Stimulation with A23187 led to highly
significant downregulation of integrin expression (F(7,16) = 30.074,
p \ 0.001), starting at 30 min, as shown by Tukey post-hoc
comparison. In contrast, neither unstimulated (F(7,16) = 0.561,
p = 0.767), nor anti-IgE-stimulated cells (F(7,16) = 0.775,
p = 0.617) showed any significant VLA-4 surface expression
changes
Fig. 5 Attachment of RBL-703/21 cells to FN, type I CO or LA.
20 lg/mL of each ECM protein were used for coating; cells were
activated with 1 lg/mL A23187, via crosslinking of FceRI-bound
IgE, or left untreated (control). 120 min after activation, cells were
washed and the amount of adherent cells quantified by a colorimetric
assay using crystal violet. Data expressed are mean ± SD from
triplicate determinations. Asterisks show results of unpaired t test; n.s.
not significant, **p \ 0.01, ***p \ 0.001. Data were normalised for
OD550 nm of control unstimulated cells
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(monoclonal IgE-sensitised anti-IgE-stimulated or serum-
sensitised, anti-IgE-stimulated) and threefold for the
experimental samples at optimum allergen concentration
(see Fig. 8b).
Overall fluorescence intensity was also increased
(Fig 8c). However, the main background due to the used
384-well plastics could not be eliminated or further
reduced. In comparison with the use of the GFP reporter,
the DsRed reporter showed a sharper, more pronounced
bell-shaped activation curve upon stimulation with a serial
dilution of the allergen. As can be seen from Fig. 8a,
reproducibility between experiments was also good.
Discussion
Previous work with mast cells and basophils has indicated
that FceRI surface expression is stabilised and increased up
to *17-fold after overnight incubation with its ligand IgE
[23, 24]. Significant reduction of surface IgE receptor
turnover has also been shown to occur in RBL cells incu-
bated with IgE [25, 26]. However, no previous work has
described the kinetics of FceRI a-chain surface expression
in humanised RBL, which is driven by a strong constitutive
(e.g. CMV) promoter. Thus our first step in optimising the
conditions for the basophil array was to determine the
effect of incubation with IgE on surface IgE receptor
Fig. 7 Correlation between allergen- or anti-IgE-induced GFP fluo-
rescence and released beta-hexosaminidase activity, obtained from
102 individual experiments in which cells were sensitised with serum
or IgE, and stimulated with allergen or anti-IgE, respectively
Fig. 6 a Dose-dependent induction of NF-AT/GFP reporter. An
RBL-703/21 clone sorted by FACS stably transfected with NF-AT-
hrGFP was sensitised overnight with 1:40 diluted (v/v) serum of an
allergic patient. FN-bound cells were stimulated with varying
dilutions of Bet v1 (black symbols) or Phl p1 (open symbols) in two
separate experiments (expt. 1: triangles; expt. 2: circles). Data shown
are mean fluorescence ± SD from triplicate determinations. b Nega-
tive and positive control experiments for the experiments are shown
in Fig. 6a. The mean ± SD from triplicate determinations of the RBL
NF-AT-GFP reporter unsensitised and unstimulated (cell only),
sensitised with IgE and unstimulated (IgE only), sensitised with IgE
and stimulated with anti-IgE (IgE?anti-IgE), sensitised with serum
and unstimulated (serum only) or sensitised with serum and
stimulated with anti-IgE (serum?anti-IgE) are shown. **p \ 0.01,
paired Student’s t test. n.s. not significant. c Fluorescent microscope
image (bar: 0.4 mm) of IgE/anti-IgE-stimulated RBL NF-AT-GFP
reporter cells
b
Mol Biotechnol (2014) 56:136–146 143
123
expression and on the ability to immobilise IgE-sensitised
RBL cells on the array surface via an anti-IgE antibody.
mRNA levels for human FceRI a chain were only modestly
increased with a *1.7-fold increase peaking after 4 h (data
not shown). This suggests that the increased surface levels
of FceRI a chain observed in Fig. 1, which peaked after
8–10 h, were mainly due to a stabilisation of the receptor at
the protein level rather than from induced changes in
mRNA expression, in line with the findings of Furuichi
et al. [25].
In many cells, stress fibres emanate from distinct areas of
the plasma membrane known as focal adhesions, where
clusters of integrin receptors bind to ECM proteins. Focal
adhesion proteins at the intracellular surface of the plasma
membrane include vinculin, paxillin and talin, which are
known to link F-actin with integrins [27]. Adherence to
ECM-coated surfaces results in cell spreading, reorganiza-
tion of cytoskeletal F-actin and the formation of surface
ruffles [14]. It was reported that treatment of RBL-2H3 cells
with Ca2? ionophore A23187 or anti-human IgE leads to
redistribution of vinculin to the cytoskeletal fraction [28].
Although both anti-human IgE and Ca2?-ionophore can
lead to changes of the cell surface morphology, our adhe-
sion experiment results showed that the surface levels of the
integrin VLA-4 behave very differently between the
receptor- and non-receptor-mediated activation pathways.
As a result, while inclusion of FN in the array is important
in reducing cell losses during the washing steps, A23187
but not anti-IgE stimulation leads to a pronounced RBL cell
detachment after activation even in the presence of FN.
Therefore, A23187 is clearly not a suitable positive control
for our RBL array. There are several reports describing an
increased attachment of mast cells [16, 29, 30] to ECM
proteins after activation. In such reports, attachment of
primary mast cells to ECM proteins was found to depend on
pre-activation, as in the case of bone marrow-derived
murine or peritoneal rat mast cells, via PMA [16, 31].
However, such pre-activation is not necessary for RBL
[14, 16] or MCP-5 cells [31] which are able to attach
spontaneously. Thompson et al. [29] assessed attachment of
A23187 or antigen-stimulated mast cells to LN and found
that approximately 20 % of mast cells attached to LA;
however, they did not study the detachment of previously
Fig. 8 a Dose-dependent induction of NF-AT/DsRed reporter. An
RBL-703/21 clone sorted by FACS stably transfected with NF-AT-
DsRed was sensitised overnight with 1:20 (v/v) diluted pooled serum
from ten allergic patients monosensitised to Parietaria judaica. FN-
bound cells were stimulated with varying dilutions of Par j 2 (black
circles expt.1, black triangles expt. 2). The graph also shows the lack
of DsRed induction in cells which were not sensitised with serum in
the second experiments (to control for autofluorescence of the used
allergen). Data shown are mean fluorescence ± SD from triplicate
determinations. b Negative and positive control experiments for the
experiments shown in Fig. 6a. The mean ± SD from triplicate
determinations of the RBL NF-AT-DsRed reporter unsensitised and
unstimulated (cell only), sensitised with IgE and unstimulated (IgE
only), sensitised with IgE and stimulated with anti-IgE (IgE?anti-
IgE), sensitised with serum and unstimulated (serum only) or
sensitised with serum and stimulated with anti-IgE (serum?anti-
IgE) are shown. ***p \ 0.001, paired Student’s t test. n.s. not
significant. c Fluorescent microscope image (bar: 0.4 mm) of IgE/
anti-IgE-stimulated RBL NF-AT-DsRed reporter cells
b
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attached cells after stimulation. Thus the apparent discrep-
ancies between reports in the literature describing increased
attachment to ECM after activation and our own, which
clearly demonstrate pronounced detachment after stimula-
tion with A23187, are due to differences in the protocol.
Another perhaps unexpected result was the ability of CO
and LA to bind the RBL cells and prevent losses during the
washing step. Ra et al. [15] have found that while RBL-
2H3 bound to VN and FN, they did not bind to CO and LA.
However, binding of RBL-2H3 cells to type I CO and LA,
although less pronounced than to FN, has been described
by other authors [14, 32]. Interestingly, none of the three
ECM proteins appeared to increase cell attachment after
IgE-dependent activation. Cell loss of CO-attached cells
after A23187 treatment was very similar to FN; however,
cell loss with LA was far less pronounced. This suggests
that the corresponding integrins, which partially overlap
between CO and LA but not with FN, are also differentially
regulated by A23187 activation in RBL cells.
Regarding the use of the newly developed reporter
systems, both GFP and DsRed reporter cell lines showed
the expected bell-shaped dose-dependent response. A
longer incubation of the reporter cells is needed in com-
parison with the NF-AT–Luciferase system, which is
described as optimal after 3 h [20]. While we were able to
detect increases in fluorescence as early as 8-h post stim-
ulation, these changes increased steadily for at least 20 h.
We do not know whether this reflects an issue of sensitivity
of detection or differences in the rate of synthesis or
folding of the different reporter proteins. However, the
main problem here was the low signal-to-noise ratio due to
the high background, ranging from 2- to 5-fold even under
best stimulation conditions. Our final aim is to employ the
reporter cell lines using allergen arrays with several hun-
dreds of recombinant allergens or food extracts in parallel
as previously used for Immunoglobulin determination [32].
However, the use of conventional laser array scanners is
not compatible with the use of cells growing in medium,
and commercially available laser microscopes do not have
the necessary width of field of view to record the patterns
of cellular activation at the array level. Thus our experi-
ments with the fluorescent reporter cell lines had to be
performed using 384-well plates and a Typhoon scanner,
which can be used with cells immersed in aqueous culture
medium. This type of scanner does not have the necessary
resolution at the cellular level and the plastic materials
used in 384-well cell culture plates have unacceptably high
background fluorescence for this application. We are cur-
rently developing a microscope with properties which
make them more amenable to the measurement of fluo-
rescence in aqueous environment by combining high
numerical aperture optics and tiling of mirror scans to
obtain a high-resolution image on a large surface.
In summary, we have defined optimal conditions for
the use of humanised RBL cells in array format and shown
that the inclusion of FN is essential in order to avoid cell
losses during the washing steps. A23187 is an unsuitable
positive control in this format due to a fast downregulation
of VLA-4 and subsequent detachment of cells. Using these
optimised conditions, both GFP and DsRed humanised
reporter cell lines were able to detect the presence of
allergen-specific IgE in the sera of patients and showed the
expected bell-shaped dose–response.
Our further efforts will be geared towards implementing
these optimised conditions into an automated detection
system which can be used for high-throughput assessment
of productive IgE–allergen interactions in array format.
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